Evidence map›Paper›PMID 31248037›Full record

ArticleInternational journal of molecular sciences2019

Norepinephrine Inhibits Synovial Adipose Stem Cell Chondrogenesis via α2a-Adrenoceptor-Mediated ERK1/2 Activation.

Karima El Bagdadi, Frank Zaucke, Andrea Meurer, Rainer H Straub, Zsuzsa Jenei-Lanzl

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Driving βFrontiers in immunology · 2021
    Article
  11. Article
  12. Norepinephrine Inhibits the Proliferation ofInternational journal of molecular sciences · 2020
    Article
  13. Adrenoceptor Expression during Intervertebral Disc Degeneration.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karima El BagdadiDr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, 60528 Frankfurt/Main, Germany.
Frank ZauckeDr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, 60528 Frankfurt/Main, Germany.ORCID 0000-0002-7680-9354
Andrea MeurerDr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, 60528 Frankfurt/Main, Germany.
Rainer H StraubLaboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine, University Hospital Regensburg, 93053 Regensburg, Germany.
Zsuzsa Jenei-LanzlDr. Rolf M. Schwiete Research Unit for Osteoarthritis, Orthopedic University Hospital Friedrichsheim gGmbH, 60528 Frankfurt/Main, Germany. zsuzsa.jenei-lanzl@friedrichsheim.de.
Orthopaedic University Hospital Friedrichsheim · DEUniversity Hospital Regensburg · DE

Funding

Deutsche Forschungsgemeinschaft JE642/4-1
6 · The paper itself

Abstract

In recent years, first evidences emerged that sympathetic neurotransmitters influence osteoarthritis (OA) manifestation. Joint-resident stem cells might contribute to cartilage repair, however, their chondrogenic function is reduced. The neurotransmitter norepinephrine (NE) was detected in the synovial fluid of trauma and OA patients. Therefore, the aim of this study was to analyse how NE influences the chondrogenesis of synovial adipose tissue-derived stem cells (sASCs). sASCs were isolated from knee-OA patients synovia. After adrenoceptor (AR) expression analysis, proliferation and chondrogenic differentiation in presence of NE and/or α- and β-AR antagonist were investigated. Cell count, viability, chondrogenic and hypertophic gene expression, sulfated glycosaminoglycan (sGAG) and type II collagen content were determined. Key AR-dependent signaling (ERK1/2, PKA) was analyzed via western blot. sASC expressed α1A-, α1B-, α2A-, α2B-, α2C-, and β2-AR in monolayer and pellet culture. NE did not affect proliferation and viability, but 10

Indexed as

Adipose TissueAdrenergic alpha-2 Receptor AntagonistsBiomarkersCell DifferentiationChondrogenesisGene ExpressionHumansImmunohistochemistryImmunophenotypingMAP Kinase Signaling SystemNorepinephrineOsteoarthritis, KneeReceptors, Adrenergic, alpha-2Stem CellsSynovial MembraneADRA2A protein, humanAdrenergic alpha-2 Receptor AntagonistsBiomarkersNorepinephrineReceptors, Adrenergic, alpha-2adrenoceptorschondrogenesisnorepinephrineosteoarthritisphysioxiasympathicussynovial adipose stem cells

Identifiers

PMID31248037
PMCPMC6651223
OpenAlexW2953442577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.